Chronic Kidney Disease (CKD) has become a growing challenge. A top doctor shared some of its main causes, ways to prevent it from becoming serious, and how to manage it through diet and early medical ...

Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease: Berlin Tuesday, March 17, 2026, 15:00 H ...

A 37-year-old father of two developed fatigue and rib pain. Within weeks, he was diagnosed with advanced colon cancer. He's now in a promising clinical trial.

Your kidneys do this automatically by passing your blood through millions of filtering units called nephrons, which have two main parts: the glomerulus and the tubule. The glomerulus is made up of ...

March is National Kidney Month. Learn how to protect your kidney health, recognize symptoms, and reduce your risk of disease.

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

Doctors warn that subtle symptoms like fatigue, foamy urine, swelling or lower back pain may signal early kidney problems ...

On World Kidney Day, let's understand how kidney disease often progresses silently, the warning signs to watch for, and why early screening is crucial to prevent kidney failure.

India is witnessing a worrying rise in chronic kidney disease cases, especially in young people.

A recent study published in The Lancet placed India second in the world for the number of people living with CKD, with an estimated 138 million Indians affected.

Patients with lupus nephritis complicated by thrombotic microangiopathy tend to have high death risk and poor renal outcomes. They need vital and effective therapies.

In March 2024, Fennec entered into an exclusive licensing agreement under which Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, will commercialize PEDMARQSI ® in ...